Mingbin Zheng

Title: The Innovative Contributions of Mingbin Zheng

Introduction

Mingbin Zheng is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of bio-pharmaceuticals, particularly in the detection of tumor markers through innovative reagents. His work is essential for advancing cancer diagnosis and screening processes.

Latest Patents

Mingbin Zheng holds a patent for a "Monohydroxyphenyl metabolite urine detection reagent and preparation method thereof." This reagent is designed for the detection of urine monophenolic metabolites, such as tyrosine, p-hydroxyphenyl alanine, tryptophan, and 5-hydroxyindoleacetic acid, which can serve as tumor markers. The reagent consists of an aqueous solution containing nitric acid, sulfuric acid, mercuric sulfate, mercurous nitrate, nickel nitrate, phosphomolybdic acid, and cobalt sulfate. The preparation method involves creating solutions A, B, C, D, and E, followed by mixing. This innovative reagent offers high versatility, sensitivity, and specificity, making it particularly suitable for large population screenings and clinical cancer diagnosis.

Career Highlights

Mingbin Zheng is currently employed at Jiangsu Dongbo Bio-Pharmaceutical Co. Ltd. His work at this company has allowed him to focus on developing effective diagnostic tools that can aid in cancer detection and monitoring. His contributions are vital in the ongoing fight against cancer, providing healthcare professionals with reliable methods for early detection.

Collaborations

Mingbin Zheng has collaborated with notable colleagues, including Lei Li and Dong Liu. These partnerships have fostered an environment of innovation and have contributed to the successful development of his patented technologies.

Conclusion

Mingbin Zheng's work exemplifies the importance of innovation in the field of bio-pharmaceuticals. His patented reagent for urine metabolite detection represents a significant advancement in cancer diagnostics. Through his contributions, he continues to impact the healthcare industry positively.